If we want to win the race against cancer, we cannot rely solely on genomics-based testing, argues Senior Research Fellow Joe Olechno in an article that appeared in Medicine Maker.
It’s brought unparalleled levels of precision to precision medicine, and enabled cancer treatment to be truly tailored to individual patients. Now Labcyte’s acoustic liquid handling technology will help the Institute for Molecular Medicine Finland (FIMM) take its innovative functional cell screening strategies to the next level.
Whether it be pathogen detection, biomarker quantification or genome editing, polymerase chain reaction (PCR) technology is being used across a multitude of the life sciences, due to its unprecedented levels of precision, accuracy and resolution. There is great interest in moving the latest iteration of this technology — droplet digital PCR (ddPCR) — from research labs to clinical settings, but it will require processes for method validation, verification and reproducibility.
We have launched a new section on our website dedicated to profiling our company’s greatest asset – our people. We will continue to add new profiles on a regular basis, and to feature employees from a range of departments. We’re asking them about their jobs, what excites them about their work, career advice, what they do outside of the office, and more. This is a great way to learn more about your sales manager, customer service rep or application scientist, and the many other people who make Labcyte tick.
The complex analysis of multiple data types is greatly needed in precision medicine, according to Fred Hutchinson Cancer Research Center scientist Carla Grandori. She’s striving to meet that need via SEngine, a Seattle-based enterprise that harnesses the power of genomics and robotics to create truly tailored treatment assessments for those with cancer.
Science Magazine recently published a feature article about how technologies such as the Echo Liquid Handlers are replacing human scientists to make processes more automated and efficient. Describing the lab at Labcyte customer Zymergen, a synthetic biology company in Emeryville, CA, the author writes “Instead of using a pipette to suck up and squirt microliters of liquid into each well – a tidal wave of volume on the cellular scale – the robot never touches it. Instead, 500 times per second, a pulse of sound waves causes the liquid itself to ripple and launch a droplet a thousand times smaller than one a human can transfer.”